Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients

Clinical Biochemistry

Volumn 42, Issue 7-8, 2009, Pages 595-601

  Mino, Yasuaki ^a,b   Naito, Takafumi ^a   Otsuka, Atsushi ^a   Ushiyama, Tomomi ^a   Ozono, Seiichiro ^a   Kagawa, Yoshiyuki ^b   Kawakami, Junichi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Cyclosporine; Mycophenolic acid; Mycophenolic acid acyl glucuronide; Mycophenolic acid phenol glucuronide; Pharmacokinetics; Tacrolimus

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; GLUCURONIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVALUATION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CYCLOSPORINE; FEMALE; GLUCURONIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS; YOUNG ADULT;

EID: 63649157074     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.11.013     Document Type: Article

References (33)

1. Jeong H., and Kaplan B. Therapeutic monitoring of mycophenolate mofetil. Clin J Am Soc Nephrol 2 (2007) 184-191
2. Kiberd B.A., Lawen J., Fraser A.D., Keough-Ryan T., and Belitsky P. Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am J Transplant 4 (2004) 1079-1083
3. Cransberg K., Cornelissen E.A.M., Davin J.C., et al. Improved outcome of pediatric kidney transplantations in the Netherlands - effect of the introduction of mycophenolate mofetil?. Pediatr Transplant 9 (2005) 104-111
4. Shipkova M., Armstrong V.W., Wieland E., et al. Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol 126 (1999) 1075-1082
5. Bullingham R.E., Nicholls A.J., and Kamm B.R. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34 (1998) 429-455
6. Schütz E., Shipkova M., Armstrong V.W., Wieland E., and Oellerich M. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Clin Chem 45 (1999) 419-422
7. Shipkova M., Wieland E., Schutz E., et al. The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes. Transplant Proc 33 (2001) 1080-1081
8. Wieland E., Shipkova M., Schellhaas U., et al. Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?. Clin Biochem 33 (2000) 107-113
9. Maes B., Oellerich M., Ceuppens J.L., et al. A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis. Nephrol Dial Transplant 17 (2002) 923-926
10. Shipkova M., Armstrong V.W., Weber L., et al. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit 24 (2002) 390-399
11. Heller T., van Gelder T., Budde K., et al. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. Am J Transplant 7 (2007) 1822-1831
12. van Agteren M., Armstrong V.W., van Schaik R.H., et al. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G > A gene polymorphism. Ther Drug Monit 30 (2008) 439-444
13. Srinivas T.R., Meier-Kriesche H.U., and Kaplan B. Pharmacokinetic principles of immunosuppressive drugs. Am J Transplant 5 (2005) 207-217
14. Magee C.C., and Pascual M. Update in renal transplantation. Arch Intern Med 164 (2004) 1373-1388
15. Patel C.G., Harmon M., Gohh R.Y., and Akhlaghi F. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus. Ther Drug Monit 29 (2007) 87-95
16. Ting L.S.L., Partovi N., Levy R.D., Riggs K.W., and Ensom M.H.H. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients. Ann Pharmacother 40 (2006) 1509-1516
17. Ting L.S., Partovi N., Levy R.D., Riggs K.W., and Ensom M.H. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and acyl glucuronide metabolites in stable thoracic transplant recipients. Ther Drug Monit 30 (2008) 282-291
18. Mino Y, Naito T, Matsushita T, et al. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation. Ther Drug Monit 2008; 30;656-61.
19. Naito T., Shinno K., Maeda T., et al. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Biol Pharm Bull 29 (2006) 275-280
20. Shipkova M., Armstrong V.W., Kuypers D., et al. Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report. Ther Drug Monit 23 (2001) 717-721
21. Morii M., Ueno K., Ogawa A., et al. Impairment of mycophenolate mofetil absorption by iron ion. Clin Pharmacol Ther 68 (2000) 613-616
22. Kato R., Ooi K., Ikura-Mori M., et al. Impairment of mycophenolate mofetil absorption by calcium polycarbophil. J Clin Pharmacol 42 (2002) 1275-1280
23. Naito T., Mino Y., Otsuka A., et al. Influence of metal cations on plasma trough concentration of mycophenolic acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients. Biol Pharm Bull 31 (2008) 1292-1296
24. Mino Y., Naito T., Matsushita T., Kagawa Y., and Kawakami J. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography. J Pharm Biomed Anal 46 (2008) 603-608
25. Zucker K., Tsaroucha A., Olson L., Esquenazi V., Tzakis A., and Miller J. Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. Ther Drug Monit 21 (1999) 35-43
26. Hesselink D.A., van Hest R.M., Mathot R.A., et al. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 5 (2005) 987-994
27. Kobayashi M., Saitoh H., Kobayashi M., Tadano K., Takahashi Y., and Hirano T. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats. J Pharmacol Exp Ther 309 (2004) 1029-1035
28. Westley I.S., Brogan L.R., Morris R.G., Evans A.M., and Sallustio B.C. Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine. Drug Metab Dispos 34 (2006) 261-266
29. Shipkova M., Schutz E., Armstrong V.W., Niedmann P.D., Wieland E., and Oellerich M. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite. Transplant Proc 31 (1999) 1135-1137
30. Hosotsubo H., Takahara S., Imamura R., et al. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay. Ther Drug Monit 23 (2001) 669-674
31. Westley I.S., Ray J.E., and Morris R.G. CEDIA mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipients. Ther Drug Monit 28 (2006) 632-636
32. Premaud A., Rousseau A., Picard N., and Marquet P. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry. Ther Drug Monit 28 (2006) 274-277
33. Shipkova M., Schütz E., Armstrong V.W., Niedmann P.D., Oellerich M., and Wieland E. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin Chem 46 (2000) 365-372